Hemoglobinuria - 42 Studies Found Terminated : Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH) : Paroxysmal Nocturnal Hemoglobinuria (PNH) : 2011-04-12 : Drug: ALXN1102 Single Ascendin Not yet recruiting : ALXN1210 Versus Eculizumab in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab : Paroxysmal Nocturnal Hemoglobinuria (PNH) : 2017-02-14 : Biological: ALXN1210 Completed : ALXN1210 Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) : Paroxysmal Nocturnal Hemoglobinuria (PNH) : 2016-10-25 : Biological: ALXN1210 Completed : Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent PNH Subjects : Hemoglobinuria, Paroxysmal : 2009-03-23 : Drug: Eculizumab Other Name: Soliris Completed : Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study : Paroxysmal Nocturnal Hemoglobinuria PNH : 2011-08-05 Completed : Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) : Paroxysmal Hemoglobinuria, Nocturnal : 2005-07-20 : Drug: eculizumab 600 mg intrav Active, not recruiting : A Open-label, Multiple Ascending Dose Study to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria : Paroxysmal Nocturnal Hemoglobinuria PNH : 2015-11-11 : Biological: Study Drug- ALXN1210 Approved for marketing : The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol : Hemoglobinuria, Paroxysmal : 2007-02-20 : Drug: eculizumab 600mg IV every week and 900mg IV every 2 weeks Completed : Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients : Hemoglobinuria, Paroxysmal : 2005-07-18 : Drug: eculizumab Completed : Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab : Hemoglobinuria, Paroxysmal : 2005-07-19 : Drug: eculizumab <<< Previous | Next >>>
